A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Allergic Rhinitis, Seasonal
In brief
Allergic rhinitis (AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mainly mediated by immunoglobulin E after exposure to allergens in atopic individuals. The typical symptoms of AR are paroxysmal sneezing, watery rhinorrhea, itching, and nasal congestion, which may be accompanied by ocular symptoms, including eye itching, tearing, redness, and burning sensation, which are more common in patients with hay fever allergies.
Key facts
- Study ID
- NCT07154342
- Run by
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- People needed
- 150
- Starts
- 2025-08-15
- Expected to finish
- 2026-07-31
- Last updated by the study team
- 2025-09-04
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Zhongnan Hospital of Wuhan university — Wuhan, Hubei, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.